When a company goes public, it is usually to access a broader pool of capital. But not all public channels are equal—and they’re not equally accessible. Senior exchanges Senior exchanges, such as the New York Stock Exchange and Toronto Stock Exchange, have the...
After a lackluster 2020 amid the pandemic and an economic downturn, investment in the cannabis industry has reawakened, with the amount of capital raised up 118% over 2020 as of Sept. 10. Year-to-date 2021 activity has equaled or even surpassed investment in 2019 in...
New York’s governor appointed the final two members of the board that will oversee the state’s nascent recreational marijuana program, meaning there might soon be some movement in getting the state’s adult-use market up and running.
Crowdfunding has become ubiquitous, used for everything from launching a new business idea or paying medical bills.
In a preliminary manuscript currently undergoing peer review in a well-known journal, Michael DeGregorio and other researchers offer tangible evidence that criminally prosecuting or terminating employment based solely on the presence of cannabinoids and their metabolites in blood does not inevitably comport with cognitive impairment or failure to execute activities that require high functioning.
The cannabis industry is in the early stages of figuring out how to talk, joke or maybe even dance its way to success on the burgeoning social media apps Clubhouse and TikTok.
On Sept. 13, California-based Plus Products (CSE: PLUS; OTCQX: PLPRF) filed for protection from creditors under the Companies’ Creditors Arrangement Act (CCAA), the Canadian counterpart to U.S. bankruptcy statutes.
Average daily trading volumes for U.S. cannabis operators appear to be bottoming out at about $80 million per day, a level not seen since October 2020. Trading volumes have declined 75% since peaking in February.
As long as cannabis is federally illegal in the U.S., there will be little in the way of formal protections for financial institutions that choose to work with operators in the industry.
But that doesn’t appear to be stopping every institution.
Last week, British Columbia-based Tilray (TLRY on Nasdaq, TSX), the second-largest Canadian licensed producer by market cap, announced a transaction to gain a substantial interest in U.S. cannabis retailer MedMen.
Nevada’s cannabis industry will have a new way to reach consumers with marijuana consumption lounges planned to open next year, a potential boon to businesses in a state that annually receives a large influx of tourists.
There is a disconnect between fundamental performance and stock performance for U.S. cannabis companies, resulting in compressing valuations for those operations.
